Advertisement

Topics

Latest "Animals World" News Stories

17:55 EDT 24th September 2018 | BioPortfolio

Here are the most relevant search results for "Animals World" found in our extensive news archives from over 250 global news sources.

More Information about Animals World on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Animals World for you to read. Along with our medical data and news we also list Animals World Clinical Trials, which are updated daily. BioPortfolio also has a large database of Animals World Companies for you to search.

Showing "Animals World" News Articles 1–25 of 9,600+

Monday 24th September 2018

Showcasing the Power of the Personal Story, Obesity Action Coalition (OAC) Launches Weight of ...

TAMPA, Fla., Sept. 24, 2018 /PRNewswire/ -- Obesity Action Coalition's (OAC) latest initiative, Weight of the World, is a global effort designed to link people Read more...


IDEMIA Launches Enrollment Services in the State of Colorado

BILLERICA, Mass., Sept. 24, 2018 /PRNewswire/ -- IDEMIA, the world leader in augmented identity, announces the implementation of Universal Enrollment Platform (UEP) to provide statewide Read more...

DKT International Advances the Goals of World Contraception Day, Every Day

WASHINGTON, Sept. 24, 2018 /PRNewswire/ -- DKT International is proud to share in the goals of World Contraception Day, which, according to the World Health Read more...


Legalise illicit drugs to protect health, say former heads of state

Current efforts to control drugs such as cannabis, cocaine, and heroin are causing huge avoidable harm, and governments have a duty to investigate the effect of legalising their supply, former world...

Role of 'Medicine Experts' to Be Highlighted on World Pharmacists Day

World Pharmacists Day is being celebrated Tuesday around the globe.

Hamamatsu to Distribute Energetiq’s LDLS™ Products

Energetiq’s world-class manufacturing and service augmented by Hamamatsu’s global distribution. WOBURN, Mass. (PRWEB) September 24, 2018 Energetiq Technology, a world leader in high brightness light sources for advanced technology applications, is pleased to announce that starting on October 1, 2018 Hamamatsu will distribute the company’s Laser-Driven Light Sources around the globe. Hamamat...

Why Is IVF So Popular in Denmark?

(BBC) – Despite previous attempts to limit access to treatment, Denmark now has the biggest proportion of babies born through assisted reproductive technology (ART) in the world. Visit any park in Denmark and the chances are many of the children playing … Read More

Cook Medical Receives FDA Approval for First 5 mm Diameter SFA Drug-Eluting Stent

Cook Medical announced that a new 5 mm diameter version of Zilver® PTX® was approved by the FDA. It is the first 5 mm drug-eluting stent in the U.S. with lengths available up to 140 mm that is indicated to treat vessels as small as 4mm in diameter. The range of Zilver PTX stent diameters now available will address treatment of vessel sizes from 4–7 mm ...

Eden Prairie, MN Periodontist, Dr. Andres Sanchez, Trains With World-renowned Periodontists, Treats Gum and Bone Loss With Microsurgery

Dr. Andres Sanchez, a well-regarded periodontist in Eden Prairie, MN, has completed an intensive, three-day advanced periodontal regeneration microsurgery training to help patients who experience jaw-related gum and bone loss. EDEN PRAIRIE, MN (PRWEB) September 24, 2018 PerioWest’s Dr. Andres Sanchez, has completed a three-day intensive training from two world-renowned periodontal specialists, ...

New Food Allergy Diagnostics Company, AllerGenis, Recently Launched to Deliver Innovative Diagnostic Technology Enabling More Precise Food Allergy Detection and Patient Management

Data-driven technology designed to improve patient outcomes, reduce misdiagnoses New food allergy diagnostics company, AllerGenis, LLC., recently launched for the purpose of bringing innovative, precision diagnostic solutions to food allergy clinicians, with the goal of improving patient outcomes through highly accurate and safe diagnostic tools. ...

Ping An Unveils AI Technology at International Maritime Silk Road Forum

Empowers Smart City and Healthcare HONG KONG and SHANGHAI, Sept. 24, 2018 /PRNewswire/ -- The second 21st Century Maritime Silk Road Forum on International Communication was held in Zhuhai in 19-21 September. Jean-Pierre Raffarin, former Prime Minister of France and Thomas J. Sargent, the 2011 Nobel Prize winner for Economics delivered keynote speeches at the main forum. As a leading compan...

Battelle Shows NeuroLife System’s Machine Learning Prowess in Nature Medicine

During the past four years, Battelle scientists and their colleagues at The Ohio State University Wexner Medical Center (OSU) have shown the world that patients with

Roche's investigational medicine entrectinib showed a durable response of more than two years in people with a specific type of lung cancer

F. Hoffmann-La Roche Ltd / Roche's investigational medicine entrectinib showed a durable response of more than two years in people with a specific type of lung cancer . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Entrectinib reduced tumours in people with ROS1-positive non-small cell lung cance...

FDA Approval of New Drugs One of Many Goals for Drug Manufacturers

The US pharmaceutical market, together with those of Canada and Mexico, make more than half the global pharmaceutical. The US alone is the world’s largest and it represents 45 percent of… The post FDA Approval of New Drugs One of Many Goals for Drug Ma... The post FDA Approval of New Drugs One of Many Goals for Drug Manufacturers appeared first on Biotechblog.

Roche's Tecentriq in combination with pemetrexed and platinum-based chemotherapy reduced the risk of disease worsening or death in a type of previously untreated advanced lung cancer

F. Hoffmann-La Roche Ltd / Roche's Tecentriq in combination with pemetrexed and platinum-based chemotherapy reduced the risk of disease worsening or death in a type of previously untreated advanced lung cancer . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Data will be presented at the 2018 World C...

Spectrum Pharmaceuticals Announces Release of Updated Poziotinib Data From MD Anderson Phase 2 Study in Non-Small Cell Lung Cancer Patients

Data were featured in an oral presentation at the IASLC 19th World Conference on Lung Cancer Spectrum will host a live webcast today at 4:30 p.m. Eastern/1:30 p.m. Pacific Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations...

Trial by Fire: Critics Demand That a Huge Sepsis Study Be Stopped

A trial enrolling new patients resembles “an experiment that would be conducted on laboratory animals,” one advocacy group said.

OneLegacy CEO Addresses Healthcare, Business and Government Leaders in China Regarding the Importance of Organ and Tissue Donation

OneLegacy CEO Tom Mone has joined with a distinguished international faculty in addressing healthcare, business and government leaders from across China’s Southern Yunnan province on best practices in organ and tissue donation. Mone made his remarks in Kunming, the capital city of the Yunnan province that is working to become that country’s first combi...

ComPsych® Corp. Announces 2018 Health at WorkSM Award Winners: Comcast NBCUniversal, NBA, City of Mesa, Fresenius Medical Care North America, Montgomery County, Council on Foreign Relations and Nuru International

ComPsych announced today winners of its 14th-annual Health at Work Awards, honoring organizations that support employees with exceptional wellness and well-being programs. ComPsych Corporation is the world’s largest provider of employee assistance programs and is the pioneer and worldwide leader of fully integrated EAP, behavioral health, wellness, ...

$SGMO to fine-tune #assay that will allow detection of IDS either in plasma or in peripheral lymphocytes earlier update confirming geneediting in biopsies in pts cohorts 2+3 could be possible #before WORLD $PFE HemoA best-in-class more consistent, durable

$SGMO to fine-tune #assay that will allow detection of IDS either in plasma or in peripheral lymphocytes earlier update confirming geneediting in biopsies in pts cohorts 2+3 could be possible #before WORLD $PFE HemoA best-in-class more consistent, durable ,safer than

MedTech Innovator Announces Newest Industry Partners

Nonprofit Brings on Industry Leaders Amgen, BTG, EdgeOne Medical, Fujikura, HOYA, NIPRO, Nordson Medical, and W.L. Gore MedTech Innovator, the premier nonprofit startup accelerator in the medical technology industry, today announced eight new partnerships with

Daiichi Sankyo Presents Updated Results for [Fam-] Trastuzumab Deruxtecan (DS-8201) in Patients with HER2 Mutated or HER2 Expressing Non-Small Cell Lung Cancer at IASLC 19th World Conference on Lung Cancer

-- Updated subgroup analysis from ongoing phase 1 study of [fam-] trastuzumab deruxtecan (DS-8201) demonstrated a confirmed overall response rate of 72.7 percent and a disease control rate of 100 ...

Current @IASLC President @giorgioscaglio3 at #WCLC2018 Plenary discussing society's commitment to patients with lung cancer around the world & leading largest conference on lung cancer, developing new researchers, education for docs & pts, & many other in

Current @IASLC President @giorgioscaglio3 at #WCLC2018 Plenary discussing society's commitment to patients with lung cancer around the world & leading largest conference on lung cancer, developing new researchers, education for docs & pts, & many other initiatives. #LCSM

Additional data expected at WMS. Dr. Mendell is expected to present additional data from the Phase 1 trial of the micro-dystrophin gene therapy at the World Muscle Society meetings in the coming weeks. I am excited to see

Additional data expected at WMS. Dr. Mendell is expected to present additional data from the Phase 1 trial of the micro-dystrophin gene therapy at the World Muscle Society meetings in the coming weeks. I am excited to see

First neuroblastoma patient successfully dosed with innovative CAR therapy utilizing natural killer T cells (CAR-NKT)

Cell Medica announces the treatment of the first patient world-wide to receive CMD-501, an autologous CAR-NKT therapy targeting pediatric neuroblastoma. This is the first time an engineered NKT cell therapy has been used in humans. Cell Medica is a clinical-stage biopharmaceutical company that is tr...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks